| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Roivant Sciences Ltd.'s insiders have reduced their positions by a net 1,647,800 shares worth roughly $59.9M. In the past 30 days, 0 insiders bought and 2 sold. Sales set the recent tone.
On the other side, 2 insiders reduced their position over the period. ROIV sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $2.38B | - | |
| 10% | 22.15M | - | - | |
| Pres | 18.56M | $622.45M | - | |
| CEO | 16.55M | $554.89M | - | |
| Dir | 13.69M | $482.95M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Venker Eric | President &Immunovant CEO | Sell | 200,000 | $35.11 | $7,022,667.52 | -12.5% | - | - | |
| Oct 1, 2026 | Epperly Melissa B,72 | Director | Sale+OE | 17,750 | $36.10 | $640,861.00 | -54.3% | - | - | |
| Sep 30, 2026 | Venker Eric | President &Immunovant CEO | Sale+OE | 200,000 | $36.62 | $7,324,000.00 | -11.1% | - | - | |
| Sep 15, 2026 | Fitzgerald Meghan | Director | Sell | 5,112 | $39.74 | $203,152.16 | -12.4% | - | - | |
| Sep 15, 2026 | Epperly Melissa B,72 | Director | Sell | 4,938 | $39.74 | $196,229.70 | -33.3% | - | - | |
| Sep 8, 2026 | Fitzgerald Meghan | Director | Sale+OE | 20,000 | $39.90 | $798,000.00 | -31.8% | - | - | |
| Aug 28, 2026 | Venker Eric | President &Immunovant CEO | Sale+OE | 200,000 | $35.77 | $7,153,392.58 | -11.1% | - | - | |
| Aug 21, 2026 | Sukhatme Mayukh | President &CIO | Sale+OE | 335,174 | $36.88 | $12,360,813.41 | -1.8% | - | - | |
| Aug 18, 2026 | Sukhatme Mayukh | President &CIO | Sale+OE | 664,826 | $36.34 | $24,160,401.83 | -3.4% | - | - | |
| Jul 27, 2026 | Venker Eric | President &Immunovant CEO | Sale+OE | 200,000 | $34.95 | $6,990,000.00 | -11.0% | +5.1% | - |